Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
A randomized, controlled study of standard soy milk consumption compared to 2% fat cow's milk
consumption in children with Non-alcoholic Fatty Liver Disease (NAFLD). The investigators
hypothesize that the daily consumption of soy isoflavones found in the soy milk will be
beneficial in reducing NAFLD and other obesity-related comorbidities. The investigators do
not expect any adverse endocrine or metabolomic effects from the consumption of soy
isoflavones.